"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
Descriptor ID |
D008175
|
MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 29 | 6 | 35 |
1995 | 42 | 14 | 56 |
1996 | 44 | 17 | 61 |
1997 | 48 | 19 | 67 |
1998 | 43 | 22 | 65 |
1999 | 50 | 11 | 61 |
2000 | 61 | 18 | 79 |
2001 | 54 | 23 | 77 |
2002 | 74 | 24 | 98 |
2003 | 112 | 30 | 142 |
2004 | 112 | 37 | 149 |
2005 | 114 | 32 | 146 |
2006 | 119 | 20 | 139 |
2007 | 135 | 32 | 167 |
2008 | 159 | 32 | 191 |
2009 | 121 | 33 | 154 |
2010 | 159 | 37 | 196 |
2011 | 190 | 34 | 224 |
2012 | 177 | 28 | 205 |
2013 | 183 | 33 | 216 |
2014 | 196 | 25 | 221 |
2015 | 190 | 24 | 214 |
2016 | 178 | 23 | 201 |
2017 | 191 | 34 | 225 |
2018 | 212 | 32 | 244 |
2019 | 183 | 20 | 203 |
2020 | 227 | 21 | 248 |
2021 | 223 | 7 | 230 |
2022 | 188 | 3 | 191 |
2023 | 197 | 1 | 198 |
2024 | 43 | 0 | 43 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
YIA24-001: Spatial Evolution of Immune Cell Dysfunction During Development of Oligometastatic Renal Cell Carcinoma: Secondary Analysis of a Prospective Trial. J Natl Compr Canc Netw. 2024 Apr 05; 22(2.5).
-
Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis. Mol Cancer Ther. 2024 Apr 02; 23(4):492-506.
-
An 18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy. J Nucl Med. 2024 Apr 01; 65(4):520-526.
-
Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma. Oral Oncol. 2024 Apr; 151:106759.
-
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC. J Exp Clin Cancer Res. 2024 Mar 15; 43(1):81.
-
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer Res Commun. 2024 Mar 14; 4(3):786-795.
-
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept. Cell Rep Med. 2024 Mar 19; 5(3):101463.
-
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan. Cancer Treat Rev. 2024 Apr; 125:102720.
-
Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer. Cancer Lett. 2024 Apr 28; 588:216780.
-
Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies. Cancer Epidemiol Biomarkers Prev. 2024 03 01; 33(3):389-399.